Kymera Therapeutics, Inc. (KYMR) Up 28% in 3M, Analysts See Further Upside

Kymera Therapeutics, Inc. (NASDAQ:KYMR) is among the 14 best booming stocks to buy right now. Its shares have gained over 28% in the last three months, with Wall Street anticipating a further uptick of nearly 60%, as of the close of business on January 12. Kymera Therapeutics, Inc. (KYMR) Up 28% in 3M, Analysts See Further Upside However, on January 6, Wolfe Research downgraded the stock to Peer Perform from Outperform, and according to a report on TipRanks, the firm also removed its $92 price target for ...